We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMDD icon
10801
ProShares UltraPro MidCap400
UMDD
$36M
$163K ﹤0.01%
+10,145
New +$222K
EOCW.WS
10802
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$163K ﹤0.01%
625,750
-10,814
-2% -$4.87K
YELL
10803
PUT
DELISTED
Yellow Corporation Common Stock
YELL
$163K ﹤0.01%
55,800
-24,200
-30% -$98.2K
AKBA icon
10804
Akebia Therapeutics
AKBA
$242M
$162K ﹤0.01%
457,303
+2,306
+0.5% +$968
PRQR icon
10805
ProQR Therapeutics
PRQR
$271M
$162K ﹤0.01%
+209,215
New +$156K
TFFP
10806
PUT
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$162K ﹤0.01%
1,148
-732
-39% -$102K
ASTR
10807
CALL
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$162K ﹤0.01%
8,300
-5,667
-41% -$231K
POL
10808
PUT
DELISTED
Polished.com Inc.
POL
$162K ﹤0.01%
2,654
+902
+51% +$66.5K
CEI
10809
CALL
DELISTED
Camber Energy, Inc
CEI
$162K ﹤0.01%
8,136
-5,584
-41% -$191K
SBDS
10810
PUT
DELISTED
Solo Brands Inc
SBDS
$162K ﹤0.01%
+998
New +$218K
AAOI icon
10811
Applied Optoelectronics
AAOI
$12.7B
$161K ﹤0.01%
103,786
+54,941
+112% +$135K
ETON icon
10812
CALL
Eton Pharmaceutcials
ETON
$1.68B
$161K ﹤0.01%
61,400
-3,700
-6% -$12.4K
GWH icon
10813
ESS Tech
GWH
$20.4M
$161K ﹤0.01%
3,817
+2,481
+186% +$174K
OGI
10814
CALL
Organigram Holdings
OGI
$173M
$161K ﹤0.01%
43,950
+7,975
+22% +$40.7K
VANI icon
10815
CALL
Vivani Medical
VANI
$126M
$161K ﹤0.01%
26,433
+10,333
+64% +$55.7K
VSTM icon
10816
CALL
Verastem
VSTM
$596M
$161K ﹤0.01%
11,592
+9
+0.1% +$143
SIEN
10817
DELISTED
Sientra, Inc.
SIEN
$161K ﹤0.01%
19,225
+11,668
+154% +$159K
REV
10818
CALL
DELISTED
Revlon, Inc.
REV
$161K ﹤0.01%
29,700
+14,200
+92% +$77.9K
GERN icon
10819
Geron
GERN
$943M
$160K ﹤0.01%
102,797
-269,162
-72% -$380K
UAVS icon
10820
AgEagle Aerial Systems
UAVS
$63.9M
$160K ﹤0.01%
248
+183
+282% +$152K
XGN icon
10821
Exagen
XGN
$161M
$160K ﹤0.01%
+27,996
New +$163K
DTCR icon
10822
Global X Data Center & Digital Infrastructure ETF
DTCR
$2.23B
$160K ﹤0.01%
10,796
-20,262
-65% -$313K
TCS
10823
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$160K ﹤0.01%
1,716
-2,954
-63% -$335K
CLVR
10824
CALL
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$160K ﹤0.01%
5,473
-2,887
-35% -$115K
CPUH.WS
10825
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$160K ﹤0.01%
727,531
-287
-0% -$101

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.